Document is current

Any future updates will be listed below

Erster Antikörper gegen Alzheimerdemenz kurz vor der Zulassung

Crossref DOI link: https://doi.org/10.1007/s15005-024-4190-6

Published Online: 2024-12-16

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark